Aspira Women's Health enters $4.45M ATM equity offering with H.C. Wainwright; terminates prior Cantor agreement

Aspira Women's Health Inc.

ATM agreement with H.C. Wainwright to sell up to $4,450,000 of common stock from time to time.
Wainwright receives a 3.0% commission on gross proceeds; Company reimburses certain expenses.
Prior Controlled Equity Offering agreement with Cantor Fitzgerald & Co. terminated on August 2, 2024.
Shares issued under shelf registration statement S-3 (File No. 333-278867) declared effective April 25, 2024.
Company not obligated to sell any shares and may suspend sales at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.